$31.59
-0.17-0.54%
At close: Nov 13, 4:00 PM EST
$31.59
N/A
After Hours: 4:00 PM EST
Agios Pharmaceuticals Inc
AGIONASDAQ
Agios Pharmaceuticals fell 25.3% from $42.54 to $31.76, behind the S&P 500's +12.3%. Its worst day was Nov 19 (−50.9%), and its low came Nov 19 at $22.34.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Agios Pharmaceuticals closed at its highest level of the year, 6.9% above where the year started.
+0.8% · S&P 500 −0.8%
Agios Pharmaceuticals shares rose 18.6%, while the S&P 500 rose 0.4%.
Story events cover the past 12 months · Times ET
+18.6%, the year's best day · S&P 500 +0.4%
EPS of $-1.86 beat the $-1.96 estimate on $20.0M revenue (est. $11.4M).
+1.3% · S&P 500 −1.5%
Agios Pharmaceuticals shares rose 14.3%, while the S&P 500 rose 2.9%.
+14.3% · S&P 500 +2.9%
Agios Pharmaceuticals shares fell 23.0%, while the S&P 500 fell 0.2%.
−23.0% · S&P 500 −0.2%
EPS of $-1.69 beat the $-1.79 estimate on $20.7M revenue (est. $13.8M).
+13.1% · S&P 500 0.0%
Agios Pharmaceuticals shares rose 17.7%, while the S&P 500 fell 0.5%.
+17.7% · S&P 500 −0.5%
EPS of $-1.69 beat the $-1.71 estimate on $44.7M revenue (est. $25.6M).
−6.5% · S&P 500 +1.7%
EPS of $-1.09 beat the $-1.25 estimate on $55.4M revenue (est. $50.1M).
−9.9% · S&P 500 −4.4%
Where it ended: a close of $31.76 on Nov 12, 2026. Up next: Q4 2026 earnings on Feb 11, 2027 (EPS est. $-1.11, revenue est. $62.3M).
Nothing in the past 12 months.
All AGIO dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for AGIO and SPY from Benzinga historical bars. Not investment advice.
